Serum interleukin-6 in primary fibromyalgia syndrome patients: Impact on disease burden, severity, quality of life and sleep
Aim of the work: To assess serum interleukin-6 (IL-6) level in primary fibromyalgia syndrome (FMS) patients and to study its relation to disease burden parameters Patients and methods: Forty primary FMS patients and 40 age and sex matched controls were studied. Patients answered multiple questionnai...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Egyptian Rheumatologist |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1110116421000715 |